The American Cancer Society estimates that 288,300 new cases of prostate cancer will be diagnosed in 2023. While the overall 5-year survival rate is 97%, that number goes down significantly if the ...

September is Prostate Cancer Awareness Month, and for millions of men across the U.S., it's is a crucial reminder about the ...

It's common for healthcare professionals to order biopsies for patients whom they suspect may have prostate cancer. A biopsy doesn't just rule out prostate cancer or show its presence, though. It can ...

Transrectal ultrasound guided (TRUS) biopsy has been the gold standard for prostate cancer diagnosis, but carries a significant risk of urinary tract infection, sometimes requiring hospital admission ...

Among 490 men with suspected prostate cancer, biparametric MRI (which omits dynamic contrast-enhanced sequences) detected ...

Editor's note: An earlier version of this article misidentified a source in the story. He is Jim Hu, MD, not James Hu, MD. Researchers have concluded that transperineal prostate (TP) biopsies should ...

Local anesthetic transperineal (LATP) biopsy for prostate cancer detection is gaining in popularity due to concerns about infectious complications with transrectal ultrasound (TRUS) biopsy. LATP ...

Multiparametric MRI was a game changer for prostate cancer diagnosis. Now trial findings suggest a simpler imaging protocol may be as effective.